Regent Peak Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,938
Closed -$201K 192
2024
Q3
$201K Sell
6,938
-3,772
-35% -$110K 0.05% 172
2024
Q2
$300K Sell
10,710
-49
-0.5% -$1.35K 0.07% 121
2024
Q1
$299K Sell
10,759
-2,807
-21% -$77.9K 0.08% 121
2023
Q4
$391K Sell
13,566
-199
-1% -$6.02K 0.11% 95
2023
Q3
$457K Sell
13,765
-603
-4% -$21.3K 0.14% 82
2023
Q2
$527K Sell
14,368
-336
-2% -$13.1K 0.15% 77
2023
Q1
$600K Sell
14,704
-712
-5% -$30.8K 0.19% 71
2022
Q4
$790K Buy
15,416
+648
+4% +$31.1K 0.26% 65
2022
Q3
$646K Sell
14,768
-111
-0.7% -$5.39K 0.23% 72
2022
Q2
$780K Buy
14,879
+266
+2% +$13.6K 0.25% 62
2022
Q1
$757K Buy
14,613
+184
+1% +$9.55K 0.22% 62
2021
Q4
$852K Buy
14,429
+529
+4% +$26.2K 0.23% 61
2021
Q3
$598K Buy
13,900
+180
+1% +$7.97K 0.17% 83
2021
Q2
$587K Buy
13,720
+891
+7% +$34.6K 0.16% 84
2021
Q1
$464K Buy
12,829
+6,521
+103% +$232K 0.15% 89
2020
Q4
$232K Buy
6,308
+284
+5% +$10.4K 0.08% 129
2020
Q3
$210K Buy
+6,024
New +$211K 0.09% 122
2020
Q2
Sell
-6,526
Closed -$202K 124
2020
Q1
$202K Sell
6,526
-619
-9% -$21.1K 0.11% 107
2019
Q4
$265K Buy
+7,145
New +$254K 0.12% 105

Other funds holding PFE

Regent Peak Wealth Advisors's PFE Position: Q4 2024 in Review

Regent Peak Wealth Advisors sold out of Pfizer (PFE) in Q4 2024, closing a stake of 6,938 shares — an estimated $201K sold.

Regent Peak Wealth Advisors first reported a position in PFE in Q4 2019 and held it in 19 quarters. The position peaked at $852K in Q4 2021. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Regent Peak Wealth Advisors reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Regent Peak Wealth Advisors sold 6,938 Pfizer shares in Q4 2024, an estimated $201K.
  • Regent Peak Wealth Advisors first reported a position in Pfizer in Q4 2019 and held it in 19 quarters.
  • Regent Peak Wealth Advisors's Pfizer position peaked at $852K in Q4 2021.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Regent Peak Wealth Advisors's 13F filing for Q4 2024, filed 7 Jan 2025.